Online coach aims to get heart patients moving

NCT ID NCT00265525

Completed Disease control Sponsor: Ottawa Heart Institute Research Corporation Source: ClinicalTrials.gov ↗

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study tests whether a web-based coaching program called CardioFit can help people with coronary artery disease become more physically active. Participants use a secure website to create personalized exercise plans with guidance from an online coach. The trial compares CardioFit to usual care, measuring physical activity levels and quality of life over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CardioFit (web-based physical activity coaching program)
What this could lead to: If effective, CardioFit could offer a convenient, home-based way for heart disease patients to increase physical activity and improve quality of life without needing to attend a structured rehab program.
What could go wrong: This is a relatively small trial (223 participants) testing a behavioral intervention, so results may not apply to all heart patients. The program relies on internet access and self-motivation, which may limit its effectiveness for some.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE (CAD)

Contacts and locations

Locations

London Health Sciences Centre

London, Ontario, N6A 5W9, Canada
Unversity of Ottawa Heart Institute

Ottawa, Ontario, K1Y 4W7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.